These trials, including the Glaucoma Nicotinamide Trial, Nicotinamide riboside as a neuroprotective therapy for glaucoma, Nicotinamide in Glaucoma Trial, and Targeting Metabolic Insufficiency in Glaucoma Trial, aim to evaluate various aspects of glaucoma management and neuroprotection in patients with primary open-angle glaucoma (POAG) and related conditions
Abdominal aortic aneurysm: roles of inflammatory cells
Easy measuring: At 5.0 mg/mL, 1 unit = 0.01 mL 50 mcg on a U-100 insulin syringe
A little goes a long way: one or two pumps will normally suffice
Dihexa works through HGF/c-Met allosteric potentiation with structural synaptogenesis as the primary outcomeit has no human clinical trial data and effects in animals required multi-week treatment for full expression
Injectable use carries the usual hazards of non-clinical injection injection-site reactions, and infection or abscess formation when material is not sterile or is handled improperly